Gonzalo de Miquel
Director/Board Member presso Ventaleon GmbH
Profilo
Gonzalo de Miquel is currently a Member-Supervisory Board at Ventaleon GmbH since 2017.
Previously, he worked as Director-Global Clinical Development at Almirall SA, Independent Director at ALK-Abello A, and Vice President-Clinical Development at AstraZeneca PLC.
He also served as Chief Medical Officer & Executive VP-Development at Vectura Group Ltd.
from 2017 to 2020.
Posizioni attive di Gonzalo de Miquel
| Società | Posizione | Inizio |
|---|---|---|
Ventaleon GmbH
 Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Director/Board Member | 12/10/2017 |
Precedenti posizioni note di Gonzalo de Miquel
| Società | Posizione | Fine |
|---|---|---|
| VECTURA GROUP | Chief Tech/Sci/R&D Officer | 01/03/2020 |
| ALK-ABELLÓ A/S | Director/Board Member | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ALMIRALL, S.A. | Health Technology |
| ALK-ABELLÓ A/S | Health Technology |
| Aziende private | 2 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Health Technology |
- Borsa valori
- Insiders
- Gonzalo de Miquel
